Basel
Switzerland
25
2024-11-21
The entities that hold a legal rights for patent applications filed by inventor GRETHER Uwe:
Uwe GRETHER from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF CANNABINOID RECEPTOR 2
#2 | 2024-09-19RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND
#3 | 2022-03-31Heterocyclic compounds
#4 | 2022-03-03PYRIDINE DERIVATIVES
#5 | 2021-12-16HETEROCYCLIC COMPOUNDS
#6 | 2021-09-09HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS
#7 | 2021-06-10Phenyl derivatives as cannabinoid receptor 2 agonists
#8 | 2021-05-06Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
#9 | 2021-04-22Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
#10 | 2021-04-22Radiolabeled cannabinoid receptor 2 ligand
#11 | 2021-04-22Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
#12 | 2021-04-15HETEROCYCLIC COMPOUNDS
#13 | 2021-04-15OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS
#14 | 2021-04-01HETEROCYCLIC COMPOUNDS
#15 | 2021-04-01HETEROCYCLIC COMPOUNDS
#16 | 2021-04-01HETEROCYCLIC COMPOUNDS
#17 | 2021-04-01Heterocyclic compounds
#18 | 2021-01-28Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
#19 | 2020-12-17Heterocyclic compounds
#20 | 2020-10-01HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS
#21 | 2020-10-01BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS
#22 | 2020-09-24Piperazine derivatives as MAGL inhibitors
#23 | 2020-07-30Pyridine derivatives
#24 | 2018-11-15NOVEL PYRIDINE DERIVATIVES
#25 | 2018-10-11PHENYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS
2318638 ⎘